Cancer Survivors Need More Efficient Integrated Long-Term Care and Stronger Policies Across Healthcare, Advocacy and the Workplace, New Research Concludes


The Economist Intelligence Unit Examines the Growing Worldwide Trend of Cancer Survivorship in a Bristol-Myers Squibb-sponsored research initiative

As more patients are living longer with cancer, multi-stakeholder-driven changes are required to improve integrated, or coordinated, care that addresses the range of their long-term needs, according to a new Bristol-Myers Squibb-sponsored global research initiative developed by The Economist Intelligence Unit (EIU) titled Global Cancer Survivorship: The Need for Integrated Care .

The research, released today in the lead up to World Cancer Day 2017 (February 4), reveals challenges with providing cancer services that are physically and financially accessible, and characterizes policy and practice changes necessary to deliver integrated care for cancer survivors in the long-term.

“According to a new global research initiative, greater engagement from healthcare providers, employers, patient advocates and policymakers is needed to drive effective strategies and improve efficiencies in long-term, integrated cancer care that addresses the quality of survival at all stages,” said Emmanuel Blin, Chief Strategy Officer, Bristol-Myers Squibb. “The multi-pronged research explores several concepts, including the value of cancer survivorship, and introduces powerful ideas to support the cancer community in the long-term.”

Cancer survivorship, the process of living with, through and beyond cancer, is a positive global public health trend expected to grow unprecedentedly in the next few decades because of improved diagnostics and treatments. Cancers are among the leading causes of illness and death worldwide, with approximately 14 million newly diagnosed patients and 8.2 million cancer-related deaths annually, according to the World Health Organization (WHO). Some 32.6 million people were five-year cancer survivors in 2012, the most recent data available, but the rates of survivors vary by cancer and geographies. WHO reports more developed regions have survival rates of about 1,619 people per 100,000 population, but in less developed regions, the rate falls to about 376 people.

Global Cancer Survivorship: The Need for Integrated Care is a robust initiative, resulting in a series of publications featuring actionable insights for several stakeholders. Key research outputs, available at, include:

Additional research to be published later in 2017 will explore cancer survivor policies and experiences in six countries, Brazil, France, Germany, Italy, Japan and the United States, and takes an in-depth look into the challenges cancer survivors face in these geographies.

About the Research Initiative

Bristol-Myers Squibb sponsored the Global Cancer Survivorship: The Need for Integrated Care research initiative conducted by The Economist Intelligence Unit (EIU), a world leader in global business intelligence, and the business-to-business arm of The Economist Group, which publishes The Economist newspaper. The global project examines the needs of cancer survivors and explores how governments, businesses, healthcare professionals and patient advocates support survivors, while probing additional changes they may need to make in the future.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at or follow us on LinkedIn, Twitter, YouTube and Facebook.

Media:Bristol-Myers SquibbAudrey Abernathy, 919-605-4521

Multimedia Files:

Categories: Press Releases